Vaccine Design and Testing – Multimedia

The COVID-19 pandemic didn’t just change the world – it rewrote the rules of immunology.

This whitepaper explores how peptones are revolutionizing vaccine development, offering a path to enhanced performance without the dependence on a fluctuating serum supply chain.

This interview explores expert insights into cutting-edge methodologies that overcome these challenges, providing actionable insights to optimize vaccine safety and efficacy.

This poster explores how a novel polymerase variant provides the tools needed to reduce double-stranded RNA (dsRNA) byproducts during manufacturing, ensuring the tolerability, safety and potency of mRNA vaccines and therapeutics.

This application note explores the cutting-edge tools that allow researchers to efficiently assess the integrity and purity of IVT mRNA, ensuring high-quality results.

This guide highlights key concepts in LNP formulation, offering step-by-step procedures and insights to optimize delivery outcomes.

This article explores how mRNA and VLP vaccines represent a significant advancement in vaccine technology and will play a role in protection against infectious diseases.

This whitepaper evaluates the results of a study into the three main capping options available to manufacturers, highlighting expert insights on mRNA capping costs and customer needs.

This application note outlines best practices for handling and analyzing IVT mRNA, ensuring accurate assessments of mRNA sizing, resolution and percent purity.

In this guidebook, you will discover educational resources and solutions for a number of immuno-oncology research approaches, including checkpoint inhibition, CAR T cell therapy, and cancer vaccine research.